Clinical and pathological characterization of 158 consecutive and unselected oligometastatic breast cancers in a single institution-Reference-Cited by-同舟云学术

Clinical and pathological characterization of 158 consecutive and unselected oligometastatic breast cancers in a single institution

Published:2023-02-15 Issue:3 Volume:198 Page:463-474
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Lacaze Jean-Louis^ORCID,Chira Ciprian,Glemarec Gauthier,Monselet Nils,Cassou-Mounat Thibaut,De Maio Eleonora,Jouve Eva,Massabeau Carole,Brac de la Perrière Clémence,Selmes Gabrielle,Ung Mony,Nicolai Vincent,Cabarrou Bastien,Dalenc Florence

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-023-06880-9.pdf

Reference48 articles.

1. Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol Off J Am Soc Clin Oncol 13:8–10. https://doi.org/10.1200/JCO.1995.13.1.8

2. Weichselbaum RR, Hellman S (2011) Oligometastases revisited. Nat Rev Clin Oncol 8:378–382. https://doi.org/10.1038/nrclinonc.2011.44

3. Iyengar P, Wardak Z, Gerber DE, Tumati V, Ahn C, Hughes RS et al (2018) Consolidative radiotherapy for limited metastatic non–small-cell lung cancer: a phase 2 randomized clinical trial. JAMA Oncol 4:e173501. https://doi.org/10.1001/jamaoncol.2017.3501

4. Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C et al (2019) Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with Oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. The Lancet 393:2051–2058. https://doi.org/10.1016/S0140-6736(18)32487-5

5. Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM et al (2020) Characterisation and classification of Oligometastatic disease: a European society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus recommendation. Lancet Oncol 21:e18-28. https://doi.org/10.1016/S1470-2045(19)30718-1

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ten-Year Outcomes of Stereotactic Body Radiotherapy for Oligometastatic Breast Cancer: Does Synchronous Oligometastatic Breast Cancer Benefit?;Clinical Oncology;2023-11